Michael E. Kamarck
Director at Vaxcyte, Inc. (PCVX) since October 2021
Michael E. Kamarck has filed 8 insider reports with the SEC since October 2021, as director at Vaxcyte, Inc. (PCVX), director at Passage BIO, Inc. (PASG) and director at Trillium Therapeutics Inc. (TRIL). The latest filing, on June 15, 2023, reports grant or award at Vaxcyte, Inc. (PCVX).
- Filings
- 8
- Companies
- 3
- Bought on market
- None
- Sold on market
- None
Companies where Michael E. Kamarck is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Directorsince October 2021 | 5,625 | $55.39 | Jun 15, 2023 | ||||
| Directorsince July 2022 | $3.92 | May 26, 2023 | |||||
| Director | $20.4795 | Nov 19, 2021 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jun 13, 2023PCVXSEC Form 4 filed by Kamarck Michael E.Form 4Grant or award
- May 25, 2023PASGSEC Form 4 filed by Kamarck Michael E.Form 4Grant or award
- Jul 5, 2022PASGSEC Form 4 filed by Kamarck Michael E.Form 4Grant or award
- Jul 2, 2022PASGMichael E. Kamarck became an insiderForm 3New insider
- Jun 1, 2022PCVXSEC Form 4: Kamarck Michael E. was granted 3,125 sharesForm 4Grant or award
- Nov 17, 2021TRILSEC Form 4 filed by Kamarck Michael E.Form 4Sale back to the company
- Oct 27, 2021PCVXSEC Form 4 filed by Kamarck Michael E.Form 4Grant or award
- Oct 27, 2021PCVXSEC Form 3: New insider Kamarck Michael E. claimed no ownership of stock in the companyForm 3New insider
Compare Michael E. Kamarck with
- Michael E. Kamarck vs Harpreet S. Dhaliwal1 shared
- Michael E. Kamarck vs Elvia Cowan1 shared
- Michael E. Kamarck vs Jim Wassil1 shared
- Michael E. Kamarck vs Grant Pickering1 shared
- Michael E. Kamarck vs Andrew Guggenhime1 shared
- Michael E. Kamarck vs Luis Jodar1 shared
Other insiders at the same companies
- Harpreet S. DhaliwalPCVX
- Elvia CowanPCVX
- Jim WassilPCVX
- Grant PickeringPCVX
- Andrew GuggenhimePCVX
- Luis JodarPCVX
- John MarkelsPCVX
- Lynx1 Capital Management LPPASG
- Moncef SlaouiPCVX
- Carlos V PayaPCVX
- Olivier BrandicourtPCVX
- John FureyPCVX
- Jacks LeePCVX
- Halley E GilbertPCVX
- Teri LoxamPCVX
- Anne S DrapeauPCVX
Questions about Michael E. Kamarck
- What is Michael E. Kamarck's role at Vaxcyte, Inc.?
- Michael E. Kamarck reports to the SEC as director at Vaxcyte, Inc. (PCVX), according to the latest filing on June 15, 2023. Michael E. Kamarck has also filed as director at Passage BIO, Inc. (PASG) and director at Trillium Therapeutics Inc. (TRIL).
- How many shares does Michael E. Kamarck own?
- After the latest filing that states it, Michael E. Kamarck directly owned 5,625 shares of Vaxcyte, Inc. (PCVX). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Michael E. Kamarck bought or sold stock recently?
- No open-market purchases or sales by Michael E. Kamarck are on file. The filings report grant or award and sale back to the company.
- How do I get alerts when Michael E. Kamarck files?
- Follow Michael E. Kamarck on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Michael E. Kamarck (SEC CIK 0001450730). Totals count each trade once, skipping amendments whose original is on file, from Oct 29, 2021 on. View on SEC EDGAR · Get this as JSON